Latanoprost Solution/ Drops
Product Images NDC 68462-944

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Latanoprost (NDC 68462-944). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton.jpg (Carton)

Carton.jpg (Carton)
Important information for NDC 68462-944-03 Latanoprost Ophthalmic Solution 0.005%: Store unopened bottle under refrigeration at 2°C to 8°C (36°F to 46°F). Contact dispensing pharmacy if prescription is not received within 8 days. Opened bottle may be stored at room temperature up to 25°C (77°F) for 6 weeks. During shipment, the bottle may be at temperatures up to 40°C (104°F) for 8 days. Keep out of reach of children. Distributed by Glenmark Pharmaceuticals Inc., USA. Dosage: 1 drop in the affected eye(s) in the evening. Each mL contains latanoprost 50 micrograms, benzalkonium chloride, sodium chloride, sodium dihydrogen phosphate monohydrate, and disodium hydrogen phosphate anhydrous. Suitable for mail-order patients.*
FDA Label Image

Logo.jpg (Image 01)

Logo.jpg (Image 01)
Glenmark is a pharmaceutical company that specializes in the development and manufacturing of a wide range of innovative and high-quality pharmaceutical products. They are known for their focus on research and development to bring new and advanced medical solutions to the market.*
FDA Label Image

Label.jpg (Label)

Label.jpg (Label)
This is information from a medication packaging for Latanoprost Ophthalmic Solution 0.005%. The usual dosage is one drop in the affected eye(s) in the evening. It is distributed by Glenmark Pharmaceuticals Inc. in the USA and is a product of India. The solution is sterile and intended for eye use only. The lot number and expiration date are indicated.*
FDA Label Image

Latanoprost-spl-structure (Latanoprost Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.